Detalhe da pesquisa
1.
Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19.
J Clin Med
; 11(10)2022 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628927
2.
Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster.
Cancers (Basel)
; 14(22)2022 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428631